CSL Limited Price Target Raised to $78.00 at Deutsche Bank (CSL)
Research analysts at Deutsche Bank raised their target price on shares of CSL Limited (ASX:CSL) from $71.00 to $78.00 in a report released on Sunday, Stock Ratings Network reports. The firm currently has a “buy” rating on the stock.
Shares of CSL Limited (ASX:CSL) opened at 68.690 on Friday. CSL Limited has a 52-week low of A$55.370 and a 52-week high of A$71.200. The stock has a 50-day moving average of A$69.11 and a 200-day moving average of A$67.24. The company has a market cap of A$33.476 billion and a P/E ratio of 28.28.
Several other analysts have also recently commented on the stock. Analysts at Credit Suisse reiterated an “outperform” rating on shares of CSL Limited in a research note to investors on Friday, January 24th. They now have a $74.55 price target on the stock. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of A$73.76 ($64.70).
CSL Limited is an Australia-based company. The Company is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.